stars 1 stars 2 stars 3

Currently, JointSphere is developing a novel, first in class medical device which combines proven implant technology with advanced biosciences: the JS001 plug. Implanted in the knee at the site of the cartilage defect, the JS001 plug regenerates and replaces the damaged articular cartilage, thereby fully restoring the cartilage lining of the joints. The functionality of the JS001 plug, which is comparable to articular cartilage, promises not only a favorable but also a long-term treatment effect. The development of the JS001 plug is being conducted in close collaboration with renowned scientists, academic centers and carefully selected industrial partners. The JS001 plug is not available for patients yet.

JointSphere Questions

The JointSphere annual revenue was $5.2 million in 2026.

JointSphere is based in Eindhoven, North Brabant.

The NAICS codes for JointSphere are [339, 33].

The SIC codes for JointSphere are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users